These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 23758097)

  • 1. Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases.
    Parvaneh N; Filipovich AH; Borkhardt A
    Br J Haematol; 2013 Sep; 162(5):573-86. PubMed ID: 23758097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-associated T-/natural killer cell lymphoproliferative diseases.
    Yachie A; Kanegane H; Kasahara Y
    Semin Hematol; 2003 Apr; 40(2):124-32. PubMed ID: 12704589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
    Latour S; Winter S
    Front Immunol; 2018; 9():1103. PubMed ID: 29942301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus: dermatologic associations and implications: part II. Associated lymphoproliferative disorders and solid tumors.
    Eminger LA; Hall LD; Hesterman KS; Heymann WR
    J Am Acad Dermatol; 2015 Jan; 72(1):21-34; quiz 35-6. PubMed ID: 25497918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
    Latour S; Fischer A
    Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haematological associations of Epstein-Barr virus infection.
    Okano M
    Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):199-214. PubMed ID: 10942621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Massive expansion of EBV+ monoclonal T cells with CD5 down regulation in EBV-associated haemophagocytic lymphohistiocytosis.
    Lin MT; Chang HM; Huang CJ; Chen WL; Lin CY; Lin CY; Chuang SS
    J Clin Pathol; 2007 Jan; 60(1):101-3. PubMed ID: 17213357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced therapeutic and prophylactic strategies for Epstein-Barr virus infection in immunocompromised patients.
    Okano M; Gross TG
    Expert Rev Anti Infect Ther; 2007 Jun; 5(3):403-13. PubMed ID: 17547505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disorders.
    Park S; Ko YH
    J Dermatol; 2014 Jan; 41(1):29-39. PubMed ID: 24438142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe Epstein-Barr virus infection in primary immunodeficiency and the normal host.
    Worth AJ; Houldcroft CJ; Booth C
    Br J Haematol; 2016 Nov; 175(4):559-576. PubMed ID: 27748521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic stem cell transplantation for Epstein-Barr virus-associated T/natural killer-cell lymphoproliferative disease in Japan.
    Sato E; Ohga S; Kuroda H; Yoshiba F; Nishimura M; Nagasawa M; Inoue M; Kawa K
    Am J Hematol; 2008 Sep; 83(9):721-7. PubMed ID: 18626884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
    J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Epstein-Barr virus positive T-cell lymphoproliferative disease of childhood with hemophagocytic syndrome.
    Chen G; Chen L; Qin X; Huang Z; Xie X; Li G; Xu B
    Int J Clin Exp Pathol; 2014; 7(10):7110-3. PubMed ID: 25400806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine Storm Syndromes Associated with Epstein-Barr Virus.
    Verbist K; Nichols KE
    Adv Exp Med Biol; 2024; 1448():227-248. PubMed ID: 39117818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes.
    El-Mallawany NK; Curry CV; Allen CE
    Br J Haematol; 2022 Jan; 196(1):31-44. PubMed ID: 34169507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus--associated diseases in humans.
    Kawa K
    Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus-associated lymphoproliferative disorders.
    Rezk SA; Weiss LM
    Hum Pathol; 2007 Sep; 38(9):1293-304. PubMed ID: 17707260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin.
    Beutel K; Gross-Wieltsch U; Wiesel T; Stadt UZ; Janka G; Wagner HJ
    Pediatr Blood Cancer; 2009 Aug; 53(2):184-90. PubMed ID: 19353621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TEN-like eruption in setting of EBV positive T-cell lymphoproliferative disease with HLH, in a child.
    Sharma N; Clark J; Pham H; Efron D; MacGregor D; O'Keefe R; Orchard D
    Australas J Dermatol; 2014 Aug; 55(3):e44-7. PubMed ID: 23573996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-associated lymphoproliferative disorders.
    Ambinder RF
    Rev Clin Exp Hematol; 2003 Dec; 7(4):362-74. PubMed ID: 15129648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.